Beth Israel Lahey Health and Joslin Diabetes Center have finalized an agreement for Joslin to become part of the Beth Israel Lahey system.
Joslin holds a rare niche in the local health care market as an independent clinic and research center focused exclusively on people with diabetes. Beth Israel Lahey Health is the state’s second-largest health system, including Beth Israel Deaconess Medical Center, Lahey Hospital & Medical Center, and several other hospitals.
The two organizations have been negotiating a deal since November. They still need approval from regulators before they can complete the transaction.
“With Joslin as part of Beth Israel Lahey Health, we can expand access to world-class diabetes care and leading-edge clinical trials for the diverse patients we serve backed by Joslin’s innovative diabetes research,” Dr. Kevin Tabb, chief executive of Beth Israel Lahey, said in a news release Tuesday.
Joslin and Beth Israel Deaconess Medical Center sit next to each other in Boston’s Longwood neighborhood and have a longstanding clinical affiliation for treating patients with diabetes.